Patents by Inventor Galina Skladchikova

Galina Skladchikova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for enzyme-mediated signal amplification
    Patent number: 9958449
    Abstract: The present invention relates to methods and compounds for enzyme-mediated amplification of target-associated signals for visualization of biological or chemical targets in samples, wherein the targets are immobilized, in particular the invention relates to the oxidoreductase-mediated signal amplification for visualization of targets in samples comprising cells. The methods of the invention are particular useful for qualitative and quantitative evaluation of biological markers relating to medical diagnostic and therapy.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: May 1, 2018
    Assignee: DAKO DENMARK A/S
    Inventors: Jesper Lohse, Galina Skladchikova
  • NEW METHOD FOR ENZYME-MEDIATED SIGNAL AMPLIFICATION
    Publication number: 20160274122
    Abstract: The present invention relates to methods and compounds for enzyme-mediated amplification of target-associated signals for visualization of biological or chemical targets in samples, wherein the targets are immobilized, in particular the invention relates to the oxidoreductase-mediated signal amplification for visualization of targets in samples comprising cells. The methods of the invention are particular useful for qualitative and quantitative evaluation of biological markers relating to medical diagnostic and therapy.
    Type: Application
    Filed: May 26, 2016
    Publication date: September 22, 2016
    Inventors: Jesper Lohse, Galina Skladchikova
  • Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells
    Patent number: 8071549
    Abstract: The present invention relates to a compound comprising the third Immunoglobulin (Ig3) module, and/or the fourth Immunoglobulin (Ig4) module, and/or the fifth immunoglobulin (Ig5) module, and/or the first Fibronectin III (Fn3,1) module, and/or the second Fibronectin III (Fn3,2) module of neural cell adhesion molecule (NCAM), or a fragment, or a variant thereof, capable of interacting with an Fibroblast Growth Factor (FGF) receptor and/or Adenosine-Tri-Phosphate (ATP) and/or L1, and thereby the compounds are capable of inducing differentiation, modulating proliferation, stimulate regeneration, neuronal plasticity and/or survival of cells. Further, the present invention relates to a pharmaceutical composition comprising said compound, a process of producing a pharmaceutical composition and the use of said compound.
    Type: Grant
    Filed: May 4, 2009
    Date of Patent: December 6, 2011
    Inventors: Vladislav V Kiselyov, Galina Skladchikova, Vladimir Berezin, Elisabeth Bock
  • COMPOUNDS CAPABLE OF AFFECTING DIFFERENTIATION, PROLIFERATION, REGENERATION, PLASTICITY AND SURVIVAL CELLS
    Publication number: 20090305951
    Abstract: The present invention relates to a compound comprising the third Immunoglobulin (Ig3) module, and/or the fourth Immunoglobulin (Ig4) module, and/or the fifth immunoglobulin (Ig5) module, and/or the first Fibronectin III (Fn3,1) module, and/or the second Fibronectin III (Fn3,2) module of neural cell adhesion molecule (NCAM), or a fragment, or a variant thereof, capable of interacting with an Fibroblast Growth Factor (FGF) receptor and/or Adenosine-Tri-Phosphate (ATP) and/or L1, and thereby the compounds are capable of inducing differentiation, modulating proliferation, stimulate regeneration, neuronal plasticity and/or survival of cells. Further, the present invention relates to a pharmaceutical composition comprising said compound, a process of producing a pharmaceutical composition and the use of said compound.
    Type: Application
    Filed: May 4, 2009
    Publication date: December 10, 2009
    Inventors: Vladislav V. Kiselyov, Galina Skladchikova, Vladimir Berezin, Elisabeth Bock
  • Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells
    Publication number: 20040242479
    Abstract: The present invention relates to a compound comprising the third Immunoglobulin (Ig3) module, and/or the fourth Immunoglobulin (Ig4) module, and/or the fifth Immunoglobulin (Ig5), module, and/or the first Fibronectin III (Fn3,1) module, and/or the second Fibronectin III (Fn3,2) module of neural cell adhesion molecule (NCAM), or a fragment, or a variant thereof, capable of interacting with an Fibroblast Growth Factor (FGF) receptor and/or Adenosine-Tri-Phosphate (ATP) and/or L1, and thereby the compounds are capable of inducing differentiation, modulating proliferation, stimulate regeneration, neuronal plasticity and/or survival of cells. Further, the present invention relates to a pharmaceutical composition comprising said compound, a process of producing a pharmaceutical composition and the use of said compound.
    Type: Application
    Filed: February 13, 2004
    Publication date: December 2, 2004
    Inventors: Elisabeth Bock, Vladislav V. Kiselyov, Galina Skladchikova, Vladimir Berezin